Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital

OBJECTIVES: In patients with metastatic castration-resistant prostate cancer (mCRPC), the finding of less than five circulating tumor cells (CTCs)/7.5 mL blood before start of cytotoxic treatment or shortly thereafter indicates prolonged survival. In this descriptive pilot study, we investigated whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fosså, Sophie D, Hess, Siri L, Paus, Elisabeth, Borgen, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199652/
https://www.ncbi.nlm.nih.gov/pubmed/25328865
http://dx.doi.org/10.2147/RRU.S68477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199652/
https://www.ncbi.nlm.nih.gov/pubmed/25328865
http://dx.doi.org/10.2147/RRU.S68477

Ejemplares similares